Role of RUNX2 in Melanoma: A New Player in Tumor Progression and Resistance to Therapy
RUNX2, a transcription factor, initially known for its indispensable role in skeletal development. RUNX2 is essential for osteoblast differentiation and the maintain of the osteocyte balance. RUNX2 acts directly on osteoblasts via Fgf pathway or on mesenchymal progenitors through Hedgehog, Wnt, Pthl...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76184 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Role of RUNX2 in Melanoma: A New Player in Tumor Progression and Resistance to Therapy
- Introductory Chapter: Melanoma and Therapeutic Perspectives
- Gene Therapy for Melanoma: Progress and Perspectives
- Emergence of IFN-lambda as a Potential Antitumor Agent
- New Molecular Targets for the Systemic Therapy of Melanoma
- Role of Angiogenesis and Microenvironment in Melanoma Progression
- New Insights in Cutaneous Melanoma Immune-Therapy — Tackling Immune-Suppression and Specific Anti-Tumoral Response